|
Diagnosis CD/IBDU/UC*
|
22/11/26
|
|---|
|
Male/female
|
29/30
|
|
Age at the time of the study (median, range)
|
14 yrs (2.6–18)
|
|
Prednisolone daily dose
| |
|
10 mg
|
21
|
|
5 mg
|
18
|
|
5 mg on alternate days
|
20
|
|
Length of the prednisolone therapy (months; median, range)
|
5 (0.5–39)
|
|
Maintenance medication**
| |
|
5-ASA
|
27
|
|
5-ASA and/or Aza
|
19
|
|
TNF-α-antagonist
|
11
|
|
No medication
|
2
|
- The first morning cortisol level was analyzed during weaning or at the end of oral prednisolone therapy. *CD: Crohn’s disease; IBDU: unclassified colitis; UC: ulcerative colitis. **5-ASA: 5-acetosalicylic acid; Aza: azathioprine.
